ZBTB42

Across TCGA pan-cancer cohorts, ZBTB42 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZBTB42 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in thymoma (THYM), where higher ZBTB42 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZBTB42 expression acts as an unfavorable survival marker.

THYM and ESCA are the cancer types where ZBTB42 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Median	All	0.123	0.871	<.001	12	view →
ESCA	OS	Median	II,III,IV	0.206	0.686	.004	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ZBTB42–THYM (DFS)

Open the THYM breakdown →